GRTS: מזומנים בחישוב למניה אחת gritstonebio.com

Gritstone bio, Inc. (GRTS) is currently reducing the number of its clinical projects, focusing on a colorectal cancer vaccine amid a funding shortage. Management is restructuring the business under Chapter 11 to preserve key developments. The cash per share confirms this trend, where 0.48 is the current level of the metric. Leading immunologists creating personalized therapies provide high growth potential.
פילוחי מדדים מקיפים ואנליטיקה עבור Gritstone Bio (GRTS)

This metric is calculated by dividing the total volume of liquid assets by the number of shares outstanding. This metric determines the level of absolute financial stability for each security. For Gritstone bio, Inc. (GRTS), this is a critical resource that ensures the independence of non-cyclical vaccine developments from macroeconomic shocks. An analysis of cash per share allows for an assessment of the capital's margin of safety. The cash per share trend reveals the balance between security and investment efficiency.